Lv3
350 积分 2022-02-18 加入
Exploring nondegrading molecular glues for protein–protein interactions
1个月前
已完结
Cancer-associated fibroblasts confer ALK inhibitor resistance in EML4-ALK –driven lung cancer by concurrent integrin and MET signaling
2个月前
已完结
Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK
4个月前
已完结
A case of synchronous multiple primary lung cancers each harboring an EGFR mutation or an ALK fusion gene alone that responded to osimertinib with chemotherapy
4个月前
已关闭
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
6个月前
已完结
Out with the old, in with the new: what changes in the 9th edition of the TNM classification for lung cancer?
8个月前
已完结
[Advances in diagnosis and treatment and whole process management of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer]
10个月前
已关闭
Brigatinib activates inflammasomes: Implication for immune-related adverse events
11个月前
已完结
皖公网安备34019202002308
